-
New Frontiers in Alzheimer’s
- Narrated by: Mack Sanderson, Kate Mulligan, Erica Sullivan, Traber Burns
- Length: 3 hrs and 26 mins
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Prime members: New to Audible?Get 2 free audiobooks during trial.
Pick 1 audiobook a month from our unmatched collection.
Listen all you want to thousands of included audiobooks, Originals, and podcasts.
Access exclusive sales and deals.
Premium Plus auto-renews for $14.95/mo after 30 days. Cancel anytime.
New Frontiers in Alzheimer’s
Narrated by:
Mack Sanderson, Kate Mulligan, Erica Sullivan, Traber Burns
Buy for $11.66
No default payment method selected.
We are sorry. We are not allowed to sell this product with the selected payment method
Pay using card ending in
By confirming your purchase, you agree to Audible's Conditions of Use and Amazon's Privacy Notice. Taxes where applicable.
Publisher's summary
Until recently, one idea has dominated research in treating Alzheimer’s disease: the amyloid hypothesis. Those therapies have repeatedly fallen short, and in this audiobook we take a look at where that hypothesis stands today. We examine recent research into the spectrum of disease causes, including inflammation and immune dysfunction; cutting-edge treatments, including deep-brain stimulation and magnetic resonance - guided focused ultrasound; as well as lifestyle interventions that can help protect from disease.
©2020 Scientific American, a division of Springer Nature America, Inc. (P)2021 Blackstone Publishing
activate_Holiday_promo_in_buybox_DT_T2
What listeners say about New Frontiers in Alzheimer’s
Average customer ratingsOverall
Performance
Story